在CNP类似物赛道，Ascendis的TransCon-CNP率先实现了剂型升级。与Vosoritide不一样的设计是TransCon-CNP被一层保护分子包裹，降低了体内清除影响，延长作用时间，实现每周一次给药。非头对头临床数据显示，TransCon-CNP每年2.29厘米的增高表现也优于Vosoritide。
Complete digital access to quality FT journalism with expert analysis from industry leaders. Pay a year upfront and save 20%.
，推荐阅读safew官方下载获取更多信息
Referrals matter - they help us understand the impact you’ve already had and the kind of teammate you’ll be. A strong referee can elevate your application, so choose someone who knows your skills and character well.。业内人士推荐safew官方版本下载作为进阶阅读
Pro Plan: $119.95/month